<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>.01 Participation and Evaluation. | Library of Maryland Regulations</title>
    <link rel="shortcut icon" href="/us/md/exec/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/md/exec/comar/10.10/index.full.html" data-document="href"/>
    <meta itemprop="toc-json" content="/us/md/exec/comar/10.10/index.json" data-document="href"/>
    <meta itemprop="parent-doc-url" content="/us/md/exec/comar" data-document="href"/>
    <meta itemprop="order" content="|10|10|05|.01|"/>
    <meta itemprop="doc-type" content="section" data-document=""/>
    <meta itemprop="ref-doc" content="Code of Maryland Regulations" data-document=""/>
    <meta itemprop="ref-path" content="10|10|05|.01" data-document=""/>
    <!--OpenGraph-->
    <meta property="og:url" content="/us/md/exec/comar/10.10.05.01"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content=".01 Participation and Evaluation. | Library of Maryland Regulations"/>
    <meta property="og:image" content="/us/md/exec/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#0078EF"/>
    <meta name="apple-mobile-web-app-title" content="Library of Maryland Regulations"/>
    <meta name="theme-color" content="#0078EF"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/md/exec/_document/v2/images/favicons/safari-pinned-tab.svg" color="#0078EF"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/md/exec/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/md/exec/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/md/exec/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/md/exec/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/public-sans/public-sans.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/merriweather/merriweather.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/roboto-mono/roboto-mono.css" type="text/css" rel="stylesheet" data-document=""/>
    <!--Document CSS-->
    <link href="/us/md/exec/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print" data-document=""/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js" data-document=""> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/md/exec/comar/10.10/index.full.html" as="fetch"/>
    <link rel="prefetch" href="/index.json" as="fetch"/>
    <link rel="prefetch" href="/us/md/exec/comar/10.10/index.json" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message"> </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__maryland-dsd">
      <header id="section__header" class="ns__document__maryland-dsd">
        <div id="section__header__inner" class="ns__document__maryland-dsd">
          <div id="area__logo" class="ns__document__maryland-dsd">
            <a href="/" class="logo" aria-label="Logo - Return to library home page">
              <img src="/us/md/exec/_document/v2/images/logo/logo.png" srcset="/us/md/exec/_document/v2/images/logo/logo.png 1x, /us/md/exec/_document/v2/images/logo/logo@2x.png 2x, /us/md/exec/_document/v2/images/logo/logo@3x.png 3x" alt="Library of Maryland Regulations logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__maryland-dsd">
            <div class="h__library-logotype"><span class="line1">Library of</span> <span class="line2">Maryland Regulations</span></div>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__maryland-dsd">
        <div id="section__content__inner" class="ns__document__maryland-dsd">
          <section id="area__breadcrumbs" class="ns__document__maryland-dsd" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="Library of Maryland Regulations">Library of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/md/exec/comar" title="Code of Maryland Regulations">Code of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10" data-search-heading="">
                  <a href="/us/md/exec/comar/10" title="Title 10 MARYLAND DEPARTMENT OF HEALTH">Title 10 MARYLAND DEPARTMENT OF HEALTH</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|10" data-search-heading="">
                  <a href="/us/md/exec/comar/10.10" title="Subtitle 10 LABORATORIES">Subtitle 10 LABORATORIES</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|10|05" data-search-heading="">
                  <a href="/us/md/exec/comar/10.10.05" title="Chapter 05 Medical Laboratories — Proficiency Testing">Chapter 05 Medical Laboratories — Proficiency Testing</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|10|05|.01" data-search-heading="">
                  <span title=".01 Participation and Evaluation.">.01 Participation and Evaluation.</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__maryland-dsd">
            <div class="h__document-title">Code of Maryland Regulations</div>
            <article class="content" role="document" data-ref-path="10|10|05|.01">
              <div class="tuf-authenticate">
                <h1 class="h__toc" id="/us/md/exec/comar/10.10.05.01">.01 Participation and Evaluation.</h1>
                <p class="text-indent-1 "><span class="level-num" id="A">A.</span> Participation. A licensee operating under a permit shall ensure that the laboratory:</p>
                <p class="text-indent-2 "><span class="level-num" id="A(1)">(1)</span> Enrolls in and participates satisfactorily in a PT program that meets the criteria set forth in this chapter for each of the tests that the laboratory offers to perform or performs;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(2)">(2)</span> Tests PT samples in the same manner and number of times that it routinely tests patient specimens; and</p>
                <p class="text-indent-2 "><span class="level-num" id="A(3)">(3)</span> Complies with the applicable standards contained in 42 CFR §§493.801—493.807.</p>
                <p class="text-indent-1 "><span class="level-num" id="B">B.</span> Evaluation — General. When a PT program does not evaluate a participating laboratory's PT results or the evaluated PT results are inconsistent with satisfactory performance, the participating laboratory and the OHCQ shall evaluate the PT results by comparing them to the all-method-results mean, all-instrument-results mean, or the all-participant-results mean found in the PT program's summaries of PT results.</p>
                <p class="text-indent-1 "><span class="level-num" id="C">C.</span> Evaluation — Departmental.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(1)">(1)</span> Administrative Procedures.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(1)(a)">(a)</span> Submission of Results. The OHCQ shall monitor for regulatory purposes only official results sent directly from the PT program.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(1)(b)">(b)</span> Multiple Programs. If a licensee enrolls in more than one PT program and duplicate testing and reporting occurs, the licensee shall notify the OHCQ which PT program is to be scored for regulatory purposes.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(1)(c)">(c)</span> Sample Testing. A licensee shall operate under the following PT procedures:</p>
                <p class="text-indent-4 "><span class="level-num" id="C(1)(c)(i)">(i)</span> PT samples shall be tested each time a shipment is received and for only those procedures offered or allowed under a laboratory's license;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(1)(c)(ii)">(ii)</span> If a test is no longer offered or performed, the licensee shall inform the OHCQ in writing;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(1)(c)(iii)">(iii)</span> PT samples shall be tested only in the laboratory for which they are intended;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(1)(c)(iv)">(iv)</span> PT samples shall be handled, processed, and tested in the same manner as patient specimens; and</p>
                <p class="text-indent-4 "><span class="level-num" id="C(1)(c)(v)">(v)</span> Repeat testing may not be performed on PT samples unless it is the laboratory's policy to test patients in duplicate or if abnormal test results are routinely repeated to verify accuracy.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(1)(d)">(d)</span> Testing and Reporting Deadlines.</p>
                <p class="text-indent-4 "><span class="level-num" id="C(1)(d)(i)">(i)</span> A licensee shall test PT samples and report PT results within the time limits set by the PT program.</p>
                <p class="text-indent-4 "><span class="level-num" id="C(1)(d)(ii)">(ii)</span> PT results submitted late by a licensee are deemed unsatisfactory by the PT program and the OHCQ.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(1)(e)">(e)</span> PT Program Evaluation Errors. A licensee is responsible for seeing that an evaluation error on the PT report is corrected by the PT program and that the program sends a corrected PT report to the OHCQ.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(1)(f)">(f)</span> Performance Records. A laboratory's marginal or unsatisfactory PT performance may not be changed to reflect satisfactory performance when:</p>
                <p class="text-indent-4 "><span class="level-num" id="C(1)(f)(i)">(i)</span> PT results are not submitted;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(1)(f)(ii)">(ii)</span> PT results are submitted after the due date; or</p>
                <p class="text-indent-4 "><span class="level-num" id="C(1)(f)(iii)">(iii)</span> Transcription errors involving PT results went unnoticed until the evaluated results were scored.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(2)">(2)</span> Evaluation Procedures.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(2)(a)">(a)</span> Grading Criteria.</p>
                <p class="text-indent-4 "><span class="level-num" id="C(2)(a)(i)">(i)</span> The PT program shall score test results in terms of correlation with reference or referee laboratory test results, target values, or statistical methods based on means and standard deviations.</p>
                <p class="text-indent-4 "><span class="level-num" id="C(2)(a)(ii)">(ii)</span> The OHCQ shall determine a laboratory's PT performance based on a PT program's numerical score for each specialty, subspecialty, constituent, analyte, and culture type.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(2)(b)">(b)</span> Scores. Numerical PT scores required for satisfactory performance in each subdiscipline, specialty or subspecialty are as follows:</p>
                <p class="text-indent-4 "><span class="level-num" id="C(2)(b)(i)">(i)</span> AFP for NTD, equal to or greater than 80 percent;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(2)(b)(ii)">(ii)</span> Antibodies for HIV, equal to or greater than 80 percent;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(2)(b)(iii)">(iii)</span> Bacteriology, equal to or greater than 80 percent;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(2)(b)(iv)">(iv)</span> Blood gases, equal to or greater than 80 percent;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(2)(b)(v)">(v)</span> Blood lead, equal to or greater than 80 percent;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(2)(b)(vi)">(vi)</span> Chemistry, equal to or greater than 80 percent;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(2)(b)(vii)">(vii)</span> Coagulation, equal to or greater than 80 percent;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(2)(b)(viii)">(viii)</span> Cytogenetics, as set by PT program;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(2)(b)(ix)">(ix)</span> Drugs of abuse, forensic, equal to or greater than 90 percent;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(2)(b)(x)">(x)</span> Drugs of abuse, clinical or diagnostic, equal to or greater than 80 percent;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(2)(b)(xi)">(xi)</span> Hematology, equal to or greater than 80 percent;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(2)(b)(xii)">(xii)</span> Immunohematology, ABO and Rh typing, antibody screen, 100 percent;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(2)(b)(xiii)">(xiii)</span> Immunohematology, antibody identification, equal to or greater than 90 percent;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(2)(b)(xiv)">(xiv)</span> Mycology, equal to or greater than 80 percent;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(2)(b)(xv)">(xv)</span> Mycobacteriology, equal to or greater than 80 percent;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(2)(b)(xvi)">(xvi)</span> Immunology, nonsyphilis serology, equal to or greater than 80 percent;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(2)(b)(xvii)">(xvii)</span> Parasitology, equal to or greater than 80 percent;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(2)(b)(xviii)">(xviii)</span> Syphilis serology, equal to or greater than 80 percent; and</p>
                <p class="text-indent-4 "><span class="level-num" id="C(2)(b)(xix)">(xix)</span> Urinalysis, equal to or greater than 80 percent.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(2)(c)">(c)</span> Scoring Criteria. A percent score is derived by dividing the number of satisfactory PT results by the total number of PT results for each subdiscipline, specialty, subspecialty, or individual constituent or analyte within a subspecialty.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(2)(d)">(d)</span> PT Failure. PT scores lower than the percent scores listed in <a class="internal-link " href="/us/md/exec/comar/10.10.05.01#C(2)(b)" title="">§C(2)(b) of this regulation</a> are failing scores.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(2)(e)">(e)</span> Evaluated PT Results. PT results evaluated in determining PT performance include PT results not evaluated by the PT program, code 10 results, for example, 10E, 10G, 10T, and codes of tests not performed.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(3)">(3)</span> Initial or Single PT Failure.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(3)(a)">(a)</span> Licensee Action. A licensee shall investigate a single or initial PT failure and document the corrective action taken.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(3)(b)">(b)</span> Departmental Procedures. The OHCQ shall document an initial or single PT failure and may request a licensee to submit a plan of correction and supporting documentation related to the failure.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(4)">(4)</span> Marginal PT Performance.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(4)(a)">(a)</span> Test Scores. PT performance is marginal when a laboratory exhibits failing PT scores in two of three consecutive testing events in a subdiscipline, specialty, subspecialty, or individual constituent or analyte, for example, Na, RBC, cholesterol.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(4)(b)">(b)</span> Departmental Procedures. The OHCQ shall:</p>
                <p class="text-indent-4 "><span class="level-num" id="C(4)(b)(i)">(i)</span> Document the marginal PT;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(4)(b)(ii)">(ii)</span> Send written notice of the marginal PT to the licensee; and</p>
                <p class="text-indent-4 "><span class="level-num" id="C(4)(b)(iii)">(iii)</span> Request the licensee to submit a written plan of correction.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(4)(c)">(c)</span> Laboratory Actions. A licensee shall submit to the OHCQ a written plan of correction that describes the investigation and steps taken to improve the applicable test performance.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(5)">(5)</span> Unsatisfactory PT Performance. PT performance is unsatisfactory when a laboratory exhibits:</p>
                <p class="text-indent-3 "><span class="level-num" id="C(5)(a)">(a)</span> Failing PT scores in three of four consecutive testing events in a subdiscipline, specialty, or individual constituent or analyte, for example, Na, RBC, cholesterol;</p>
                <p class="text-indent-3 "><span class="level-num" id="C(5)(b)">(b)</span> Failing PT scores in two of three consecutive testing events in a subdiscipline, specialty, subspecialty, or individual constituent or analyte, for example, Na, RBC, cholesterol, and the next PT report for the test states "test not performed"; or</p>
                <p class="text-indent-3 "><span class="level-num" id="C(5)(c)">(c)</span> An average PT score for a test over the last four consecutive testing events that falls below the minimum percent score set forth in <a class="internal-link " href="/us/md/exec/comar/10.10.05.01#C(2)(b)" title="">§C(2)(b) of this regulation</a>.</p>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__maryland-dsd" aria-label="Previous and next article links">
            <section>
              <a href="/us/md/exec/comar/10.10.05" aria-label="Chapter 05 Medical Laboratories — Proficiency Testing">
                <div class="h__ui">Previous</div>
                <span>Chapter 05 Medical Laboratories — Proficiency Testing</span>
              </a>
            </section>
            <section>
              <a href="/us/md/exec/comar/10.10.05.02" aria-label=".02 Discipline, Specialty, and Subspecialty.">
                <div class="h__ui">Next</div>
                <span>.02 Discipline, Specialty, and Subspecialty.</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__maryland-dsd">
        <div id="section__footer__inner" class="ns__document__maryland-dsd">
          <div id="area__footer__content" class="ns__document__maryland-dsd">
            <p>The codes and laws on this page are released under a CC-BY-SA license. 180 days after publication they will be dedicated to the public domain under the CC0 license.</p>
            <p>
      Please do not scrape. Instead, bulk download the CC-BY-SA <a href="https://github.com/maryland-dsd/law-html">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml">XML</a> or CC0 <a href="https://github.com/maryland-dsd/law-html-cc0">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml-cc0">XML</a>.
    </p>
            <p>Powered by the non-profit <a href="https://www.openlawlib.org/">Open Law Library</a>.</p>
          </div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
